Teclistamab in Relapsed or Refractory Multiple Myeloma.
N Engl J Med. 2022 Aug 11;387(6):495-505. doi: 10.1056/NEJMoa2203478. Epub 2022 Jun 5.
N Engl J Med. 2022.
PMID: 35661166
Clinical Trial.